Catherine Pellat‐Deceunynck

5.7k total citations
98 papers, 3.7k citations indexed

About

Catherine Pellat‐Deceunynck is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Catherine Pellat‐Deceunynck has authored 98 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 44 papers in Hematology and 34 papers in Immunology. Recurrent topics in Catherine Pellat‐Deceunynck's work include Multiple Myeloma Research and Treatments (44 papers), Cell death mechanisms and regulation (17 papers) and Ubiquitin and proteasome pathways (16 papers). Catherine Pellat‐Deceunynck is often cited by papers focused on Multiple Myeloma Research and Treatments (44 papers), Cell death mechanisms and regulation (17 papers) and Ubiquitin and proteasome pathways (16 papers). Catherine Pellat‐Deceunynck collaborates with scholars based in France, United States and Canada. Catherine Pellat‐Deceunynck's co-authors include Régis Bataille, Martine Amiot, Gaëtan Jégo, Nelly Robillard, Philippe Moreau, Géraldine Descamps, Jean‐Luc Harousseau, Steven Le Gouill, Patricia Gomez‐Bougie and David Chiron and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Catherine Pellat‐Deceunynck

94 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Pellat‐Deceunynck France 36 1.9k 1.5k 1.3k 1.2k 523 98 3.7k
Nelly Robillard France 34 1.6k 0.8× 1.7k 1.1× 1.1k 0.8× 1.2k 1.0× 641 1.2× 94 3.8k
Jacalyn Rosenblatt United States 31 1.5k 0.8× 1.3k 0.8× 1.2k 1.0× 1.7k 1.4× 217 0.4× 142 3.5k
Geoffrey L. Uy United States 32 1.6k 0.9× 2.9k 1.9× 900 0.7× 1.5k 1.2× 536 1.0× 214 4.6k
Amitabha Mazumder United States 29 1.6k 0.9× 1.7k 1.1× 1.7k 1.4× 1.6k 1.3× 293 0.6× 110 3.9k
Pearlie K. Epling‐Burnette United States 34 1.2k 0.6× 1.6k 1.0× 1.9k 1.5× 1.0k 0.8× 1.2k 2.3× 113 4.0k
Renate Burger Germany 27 1.6k 0.8× 990 0.6× 628 0.5× 1.1k 0.9× 221 0.4× 66 2.9k
Ulrich Steidl United States 40 2.5k 1.3× 2.1k 1.4× 1.1k 0.9× 810 0.6× 739 1.4× 126 4.7k
Daniele Caracciolo Italy 35 1.9k 1.0× 1.2k 0.8× 837 0.7× 1.1k 0.9× 416 0.8× 121 4.0k
Yazan Alsayed United States 29 2.2k 1.2× 1.9k 1.3× 529 0.4× 1.5k 1.2× 309 0.6× 61 3.1k
François Sigaux France 30 1.8k 0.9× 989 0.6× 1.1k 0.9× 954 0.8× 542 1.0× 76 3.8k

Countries citing papers authored by Catherine Pellat‐Deceunynck

Since Specialization
Citations

This map shows the geographic impact of Catherine Pellat‐Deceunynck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Pellat‐Deceunynck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Pellat‐Deceunynck more than expected).

Fields of papers citing papers by Catherine Pellat‐Deceunynck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Pellat‐Deceunynck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Pellat‐Deceunynck. The network helps show where Catherine Pellat‐Deceunynck may publish in the future.

Co-authorship network of co-authors of Catherine Pellat‐Deceunynck

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Pellat‐Deceunynck. A scholar is included among the top collaborators of Catherine Pellat‐Deceunynck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Pellat‐Deceunynck. Catherine Pellat‐Deceunynck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2026). CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival. Leukemia.
2.
Maïga, Sophie, Christelle Dousset, Agnès Moreau‐Aubry, et al.. (2025). VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target. Leukemia. 39(4). 995–1000.
3.
Bellanger, Céline, Benoît Tessoulin, Christelle Dousset, et al.. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. 109(8). 2574–2584. 1 indexed citations
4.
Maïga, Sophie, Céline Bellanger, Catherine Pellat‐Deceunynck, et al.. (2023). BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival. Frontiers in Oncology. 13. 1196005–1196005. 4 indexed citations
5.
Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations
6.
Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations
7.
Maïga, Sophie, Cyrille Touzeau, Céline Bellanger, et al.. (2020). Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes. Cell Death and Disease. 11(5). 316–316. 34 indexed citations
8.
Descamps, Géraldine, Sophie Maïga, Benoît Tessoulin, et al.. (2017). Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells. International Journal of Molecular Sciences. 19(1). 40–40. 3 indexed citations
9.
10.
Lodé, Laurence, Philippe Moreau, Catherine Godon, et al.. (2013). Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease. Blood Cancer Journal. 3(11). e163–e163. 3 indexed citations
11.
Surget, Sylvanie, David Chiron, Patricia Gomez‐Bougie, et al.. (2012). Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells. Cancer Research. 72(17). 4562–4573. 58 indexed citations
12.
Touzeau, Cyrille, Christelle Dousset, Patricia Gomez‐Bougie, et al.. (2011). ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells with a Bcl-2 high /Mcl-1 low Profile and Synergizes with Other Antineoplastic Agents. Clinical Cancer Research. 17(18). 5973–5981. 49 indexed citations
13.
Chiron, David, et al.. (2011). TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells. SHILAP Revista de lepidopterología. 2. 83–83. 22 indexed citations
14.
Moreaux, Jérôme, Bernard Klein, Régis Bataille, et al.. (2010). A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica. 96(4). 574–582. 124 indexed citations
15.
Ménoret, Emmanuelle, Patricia Gomez‐Bougie, Sylvanie Surget, et al.. (2009). Mcl‐1128–350 fragment induces apoptosis through direct interaction with Bax. FEBS Letters. 584(3). 487–492. 12 indexed citations
16.
Ménoret, Emmanuelle, Sophie Maïga, Géraldine Descamps, et al.. (2008). IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop. The Journal of Immunology. 181(10). 6837–6842. 30 indexed citations
17.
Rawstron, Andy C., Alberto Órfão, Gema Mateo, et al.. (2007). Report of the European Myeloma Network (EMN) workshop on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica.
18.
Descamps, Géraldine, et al.. (2004). The Magnitude of Akt/Phosphatidylinositol 3′-Kinase Proliferating Signaling Is Related to CD45 Expression in Human Myeloma Cells. The Journal of Immunology. 173(8). 4953–4959. 34 indexed citations
19.
Robillard, Nelly, Gaëtan Jégo, Catherine Pellat‐Deceunynck, et al.. (1998). CD28, a marker associated with tumoral expansion in multiple myeloma.. PubMed. 4(6). 1521–6. 80 indexed citations
20.
Page, Cécile Le, Catherine Pellat‐Deceunynck, Jean‐Claude Drapier, & Juana Wietzerbin. (1997). Effects of Inhibitors of ADP-Ribosylation on Macrophage Activation. Advances in experimental medicine and biology. 419. 203–207. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nelly Robillard Breakdown of academic impact, for papers by Jacalyn Rosenblatt Breakdown of academic impact, for papers by Geoffrey L. Uy Breakdown of academic impact, for papers by Amitabha Mazumder Breakdown of academic impact, for papers by Pearlie K. Epling‐Burnette Breakdown of academic impact, for papers by Renate Burger Breakdown of academic impact, for papers by Ulrich Steidl Breakdown of academic impact, for papers by Daniele Caracciolo Breakdown of academic impact, for papers by Yazan Alsayed Breakdown of academic impact, for papers by François Sigaux
Rankless by CCL
2026